Searchable abstracts of presentations at key conferences in endocrinology

ea0044p254 | Thyroid | SFEBES2016

An Audit on Fixed dose (555 MBq) Radioactive-iodine for Hyperthyroidism at a University Hospital

Vijay Arun Muthukaruppan Alagar , Cooper Julie , Varadhan Lakshminarayanan , Nayak Ananth U

Background/Aim: Radioactive-iodine (RAI) therapy aims to cure hyperthyroidism, with some International authorities recommending a sufficient RAI dose to render patients hypothyroid. An audit on low dose RAI (<400 MBq) at our University Hospital in 2014 suggested above national average rates of Thyrotoxicosis relapse (24%) and lower rates of hypothyroidism (41%) 6-months post RAI. From 2015, a fixed dose (555 MBq) RAI was utilised and we present the audit outcomes using thi...

ea0059p047 | Bone and calcium | SFEBES2018

Clinical efficacy of cinacalcet in primary hyperparathyroidism in reducing calcium and admission avoidance

Varadhan Lakshminarayanan , Nayak Ullal Ananth , Katreddy Mahesh , Cooper Julie , Varughese George

Aim: Cinacalcet is a useful treatment option in primary hyperparathyroidism (PHPT) who are managed conservatively; however there are licensing issues and challenges for prescribing in primary care. The aim of our study was to assess the efficacy of cinacalcet treatment in PHPT and benefit of admission avoidance.Methods: Data on patients treated with cinacalcet for PHPT were analysed. PTH, adjusted calcium and vitamin D at initiation, calcium at 6 and 12 ...